Magnesium Sulfate Tocolysis and Intraventricular Hemorrhage in Very Preterm Infants
- 317 Downloads
To estimate the contributory effect of tocolytic magnesium sulfate (MgSO4) exposure to intraventricular hemorrhage (IVH) in preterm infants born at 23–31 wks gestation to mothers without evidence of pregnancy induced hypertension and/or preeclampsia.
Cases with IVH and controls without IVH were selected from a population-based cohort of preterm infants admitted from January 2004 through May 2008 to the Level III Neonatal Intensive Care Unit (NICU) at Robert Wood Johnson University Hospital. Cases and controls were matched primarily by exact gestational age in completed weeks and secondarily by the birth weight that was same or similar (+/−100 g). The odds of tocolytic MgSO4 exposure among the cases and controls was tested in a regression model to control the difference in demographic and clinical factors between the IVH cases (IVH+) and controls without IVH (IVH-).
Eighty-nine IVH cases and 89 controls were comparable for parity, mode of delivery, antenatal corticosteroid exposure, and surfactant administration. IVH cases were less likely to have preterm premature rupture of membranes and were more likely to be born with low Apgar scores and require ventilation. Among the IVH cases, 30.3% of infants were exposed to tocolytic MgSO4 as compared to 47.2% of controls (Odds Ratio adjusted 0.471, 95% Confidence Interval 0.241, 0.906).
Among the preterm born infants with gestational age 23–31 wks and IVH, tocolytic MgSO4 exposure was less likely to be observed than in neonates with similar clinical characteristics but without IVH, thereby suggesting that antenatal exposure to MgSO4 may have a protective effect against IVH.
KeywordsPreterm neonates Intraventricular hemorrhage Magnesium sulfate tocolysis
The authors would like to thank Mayoor Bhatt, Aileen Arriola, Richard Ruben, and Rohan Alaigh for their help in the data extraction.
Conflict of Interest
Role of Funding Source
This study was supported in part by a grant from the Memorial Research Fund.
- 3.Mittendorf R, Pryde PG. A review of the role for magnesium sulfate in preterm labor. BJOG. 2005;11:84–8.Google Scholar
- 13.Marret S, Marpeau L, Follet-Bouhamed C, Cambonie G, Astruc D, Delaporte B, et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (old less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil. 2008;36:278–88.PubMedCrossRefGoogle Scholar
- 15.American College of Obstetrics and Gynecology, Task Force on Neonatal Encephalopathy and Cerebral Palsy, American Academy of Pediatrics. Neonatal encephalopathy and cerebral palsy: defining the pathogenesis and pathophysiology. Washington: American College of Obstetricians and Gynecologists; 2003.Google Scholar
- 19.Volpe JJ. Intracranial hemorrhage: germinal matrix- intraventricular hemorrhage of the premature infant. Neurology of the Newborn. 5th ed. Philadelphia: Saunders Elsevier; 2008. p. 517–88.Google Scholar
- 29.Gawaz M, Ott I, Reininger AJ, Neumann FJ. Effects of magnesium on platelet aggregation and adhesion: magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Tromb Haemost. 1994;72:912–8.Google Scholar